Tag Archives: Getting

For Some Patients Financial Toxicity Is Real And Getting Worse

The Trump Administration has not been shy about being critical of drug prices, transparency, and other issues it sees as plaguing the prescription drug market. One can say that this Administration has been more proactive in this area than any other Administration. While from a policy perspective drug price transparency and a better functioning prescription… Read More »